Ophthalmology. 1987 Jul;94(7):761-74. doi: 10.1016/s0161-6420(87)33527-4.
The Early Treatment Diabetic Retinopathy Study (ETDRS) has recently shown that argon laser photocoagulation treatment is beneficial in reducing the risk of visual loss from clinically significant diabetic macular edema. The ETDRS treatment consisted of a combination of focal treatment to individual-leaking microaneurysms and grid treatment to areas of diffuse leakage and capillary nonperfusion. These techniques are described in detail, and the concepts of "clinically significant macular edema" and "treatable lesions" are defined. Guidelines for the application of ETDRS findings to clinical practice are discussed.
早期糖尿病性视网膜病变研究(ETDRS)最近表明,氩激光光凝治疗有助于降低临床上显著的糖尿病性黄斑水肿导致视力丧失的风险。ETDRS治疗包括对单个渗漏微动脉瘤进行局部治疗以及对弥漫性渗漏和毛细血管无灌注区域进行格栅样治疗。这些技术得到了详细描述,并且定义了“临床上显著的黄斑水肿”和“可治疗病变”的概念。文中还讨论了将ETDRS研究结果应用于临床实践的指南。